ATE320809T1 - Polymorphe, amorphe und hydratisierte formen von 5-chlor-3-(methansulfonylphenyl)-6'-methyl-2, 3')bipyridinyl - Google Patents
Polymorphe, amorphe und hydratisierte formen von 5-chlor-3-(methansulfonylphenyl)-6'-methyl-2, 3')bipyridinylInfo
- Publication number
- ATE320809T1 ATE320809T1 AT00980817T AT00980817T ATE320809T1 AT E320809 T1 ATE320809 T1 AT E320809T1 AT 00980817 T AT00980817 T AT 00980817T AT 00980817 T AT00980817 T AT 00980817T AT E320809 T1 ATE320809 T1 AT E320809T1
- Authority
- AT
- Austria
- Prior art keywords
- amorphous
- methansulfonylphenyl
- polymorphous
- bipyridinyl
- chlorine
- Prior art date
Links
- 102000010907 Cyclooxygenase 2 Human genes 0.000 abstract 2
- 108010037462 Cyclooxygenase 2 Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16792299P | 1999-11-29 | 1999-11-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE320809T1 true ATE320809T1 (de) | 2006-04-15 |
Family
ID=22609368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00980817T ATE320809T1 (de) | 1999-11-29 | 2000-11-27 | Polymorphe, amorphe und hydratisierte formen von 5-chlor-3-(methansulfonylphenyl)-6'-methyl-2, 3')bipyridinyl |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US6441002B1 (https=) |
| EP (1) | EP1248618B1 (https=) |
| JP (1) | JP4425514B2 (https=) |
| AT (1) | ATE320809T1 (https=) |
| AU (1) | AU776544B2 (https=) |
| CA (1) | CA2391650C (https=) |
| DE (1) | DE60026877T2 (https=) |
| DK (1) | DK1248618T3 (https=) |
| ES (1) | ES2259295T3 (https=) |
| PT (1) | PT1248618E (https=) |
| WO (1) | WO2001037833A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12001001175B1 (en) * | 2000-05-26 | 2006-08-10 | Merck Sharp & Dohme | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- (2,3')bipyridinyl in pure crystalline form and process for synthesis |
| US6521642B2 (en) | 2000-05-26 | 2003-02-18 | Merck & Co., Inc. | 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl in pure crystalline form and process for synthesis |
| WO2005085199A1 (en) * | 2004-01-14 | 2005-09-15 | Cadila Healthcare Limited | Novel polymorphs of etoricoxib |
| PL2479166T3 (pl) | 2009-02-27 | 2014-11-28 | Cadila Healthcare Ltd | Sposób otrzymywania etorykoksybu |
| WO2012163839A1 (en) | 2011-05-27 | 2012-12-06 | Farma Grs, D.O.O. | A process for the preparation of polymorphic form i of etoricoxib |
| EP2773618A1 (en) | 2011-11-03 | 2014-09-10 | Cadila Healthcare Limited | An improved process for the preparation of etoricoxib and polymorphs thereof |
| WO2013075732A1 (en) | 2011-11-21 | 2013-05-30 | Synthon Bv | Process for making crystalline form i of etoricoxib |
| EP2601952A1 (en) | 2011-12-07 | 2013-06-12 | Zentiva, k.s. | Novel pharmaceutically acceptable salts and cocrystals of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl and their therapeutic uses |
| EP2831045A2 (en) * | 2012-03-30 | 2015-02-04 | Mylan Laboratories, Limited | An improved process for the preparation of etoricoxib |
| EP2888231B1 (en) | 2012-08-27 | 2019-01-09 | Glenmark Pharmaceuticals Limited | Process for preparation of crystalline etoricoxib |
| CN104418799A (zh) * | 2013-09-03 | 2015-03-18 | 天津药物研究院 | 一种依托考昔的晶型及其制备方法和应用 |
| WO2015036550A1 (en) | 2013-09-13 | 2015-03-19 | Synthon B.V. | Process for making etoricoxib |
| CN107056691B (zh) * | 2017-06-21 | 2020-03-10 | 四川尚锐生物医药有限公司 | 一种制备依托考昔晶型v的方法 |
| MX2018013070A (es) | 2017-12-29 | 2019-10-15 | Gruenenthal Gmbh | Combinación farmacéutica que comprende clorhidrato de tramadol de liberación extendida y etoricoxib de liberación inmediata, y su uso para el tratamiento del dolor. |
| CN111410629A (zh) * | 2020-03-31 | 2020-07-14 | 天津大学 | 依托考昔溶剂化物及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5321033A (en) | 1991-11-15 | 1994-06-14 | Merck Frosst Canada, Inc. | Amorphous (quinolin-2-ylmethoxy)indole compounds useful for treating inflammatory diseases |
| IL127441A (en) | 1996-07-18 | 2003-02-12 | Merck Frosst Canada Inc | Substituted pyridines, pharmaceutical compositions comprising them and their use in the preparation of anti-inflammatory medicaments or as selective cyclooxygenase-2 inhibitors |
| US5861419A (en) * | 1996-07-18 | 1999-01-19 | Merck Frosst Canad, Inc. | Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| US6127545A (en) | 1997-04-18 | 2000-10-03 | Merck & Co., Inc. | Process for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 inhibitors |
| US6130334A (en) | 1998-04-15 | 2000-10-10 | Merck & Co., Inc. | Process for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 inhibitors |
| US6040450A (en) | 1997-09-25 | 2000-03-21 | Merck & Co., Inc. | Process for making diaryl pyridines useful as cox-2-inhibitors |
| HU227627B1 (en) * | 1998-04-24 | 2011-10-28 | Merck Sharp & Dohme | Process for synthesizing pyridine derivatives as cox-2 inhibitors and the intermediates |
| US6521642B2 (en) * | 2000-05-26 | 2003-02-18 | Merck & Co., Inc. | 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl in pure crystalline form and process for synthesis |
| PH12001001175B1 (en) * | 2000-05-26 | 2006-08-10 | Merck Sharp & Dohme | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- (2,3')bipyridinyl in pure crystalline form and process for synthesis |
-
2000
- 2000-11-27 CA CA2391650A patent/CA2391650C/en not_active Expired - Lifetime
- 2000-11-27 AT AT00980817T patent/ATE320809T1/de active
- 2000-11-27 EP EP00980817A patent/EP1248618B1/en not_active Expired - Lifetime
- 2000-11-27 PT PT00980817T patent/PT1248618E/pt unknown
- 2000-11-27 DK DK00980817T patent/DK1248618T3/da active
- 2000-11-27 WO PCT/US2000/032353 patent/WO2001037833A1/en not_active Ceased
- 2000-11-27 DE DE60026877T patent/DE60026877T2/de not_active Expired - Lifetime
- 2000-11-27 JP JP2001539448A patent/JP4425514B2/ja not_active Expired - Lifetime
- 2000-11-27 AU AU18031/01A patent/AU776544B2/en not_active Expired
- 2000-11-27 ES ES00980817T patent/ES2259295T3/es not_active Expired - Lifetime
- 2000-11-28 US US09/724,522 patent/US6441002B1/en not_active Expired - Lifetime
-
2002
- 2002-06-26 US US10/180,399 patent/US20020198238A1/en not_active Abandoned
-
2003
- 2003-01-14 US US10/342,379 patent/US20030144327A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US6441002B1 (en) | 2002-08-27 |
| EP1248618A4 (en) | 2003-05-14 |
| JP4425514B2 (ja) | 2010-03-03 |
| AU776544B2 (en) | 2004-09-16 |
| US20030144327A1 (en) | 2003-07-31 |
| US20020198238A1 (en) | 2002-12-26 |
| EP1248618A1 (en) | 2002-10-16 |
| CA2391650A1 (en) | 2001-05-31 |
| DE60026877T2 (de) | 2006-11-23 |
| AU1803101A (en) | 2001-06-04 |
| WO2001037833A1 (en) | 2001-05-31 |
| CA2391650C (en) | 2011-01-25 |
| DK1248618T3 (da) | 2006-07-10 |
| JP2003514859A (ja) | 2003-04-22 |
| DE60026877D1 (de) | 2006-05-11 |
| EP1248618B1 (en) | 2006-03-22 |
| PT1248618E (pt) | 2006-07-31 |
| ES2259295T3 (es) | 2006-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE320809T1 (de) | Polymorphe, amorphe und hydratisierte formen von 5-chlor-3-(methansulfonylphenyl)-6'-methyl-2, 3')bipyridinyl | |
| ID19602A (id) | Piridin tersubstitusi sebagai inhibitor selektif siklooksigenase-2 | |
| PT1240104E (pt) | Producao continua de microgeis de base em silica | |
| WO2001085978A3 (en) | Method for high-throughput lead profiling | |
| CY2007024I1 (el) | Kαινοφανη παραγωγα 3.3-διαφαινυλοπροπυλινων | |
| DE60105443D1 (de) | Geschäumte bohrlochzementschlämme | |
| AU4677199A (en) | Multibinding inhibitors of topoisomerase | |
| ATE211732T1 (de) | N-benzylpiperidin- und tetrahydropyridin-derivate | |
| IS6338A (is) | 4-karboxýamínó-2-etýl-1,2,3,4-tetrahýdrókínólín kristall sem CETP lati | |
| NO20024623L (no) | Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallform | |
| NO20023549L (no) | Fremgangsmåte for rensing av 1,2-dikloretan | |
| NO993132L (no) | Sementeringsslagg for en brönn, saerlig en oljebrönn | |
| NO20010298D0 (no) | Polymorf av et formakum | |
| ATE282038T1 (de) | Kristallin form ii von cabergolin | |
| DE69607949D1 (de) | Doppeltes bohrlochsteigrohr | |
| NO20020717D0 (no) | Produksjon av dampavsatt silika | |
| AR028607A1 (es) | Derivados de 1,4-diazepan-2,5-diona | |
| NO20005285L (no) | Styring av multiple nedihullsverktöy | |
| ID22326A (id) | Struktur montasi sarung garpu | |
| DE59913178D1 (de) | Bohrgestängeverbinder | |
| EE05234B1 (et) | 6-karboksamidoimidaso[1,2-a] pridiinihendite kasutamine ravimi p?hjustatud maohaavandi vltimiseks | |
| NO20011056L (no) | Fremgangsmate for utvelging av stivelse | |
| KR970002359U (ko) | 가스캔 구멍뚫이개 | |
| SI1248618T1 (sl) | Polimorfne, amorfne in hidratirane oblike 5-kloro-3-(4-metansulfonilfenil)-6'-metil-2,3')bipiridinila | |
| ES1045877Y (es) | Disposicion de fieltros autoadhesivos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1248618 Country of ref document: EP |
|
| EEFA | Change of the company name |